AVXL insider filings
ANAVEX LIFE SCIENCES CORP. — 41 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-05. Screen AVXL transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 3 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Boenisch Sandra — PFO & Treasurer | 1 | — | — | 4 |
| Patel Gautam — Director | 1 | — | — | — |
| Senderowicz Adrian — Director | 1 | — | — | — |
Recent insider filings — ANAVEX LIFE SCIENCES CORP.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 3 | Senderowicz Adrian — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-05 | 3 | Patel Gautam — Director | Holdings only — no transactions reported | EDGAR |
| 2026-09-28 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Option exercise (M): 187,500 @ $5.04 · Tax withholding (F): 145,048 @ $9.58 · Option exercise (M): 187,500 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Thomas Steffen — Director | Option exercise (M): 50,000 @ $1.76 · Tax withholding (F): 11,349 @ $7.75 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Donhauser Peter D.O. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Ma Jiong — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Skarpelos Athanasios — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Thomas Steffen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Velden Claus Vander — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Option exercise (M): 500,000 @ $0.92 · Tax withholding (F): 282,497 @ $9.63 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 166,666 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Donhauser Peter D.O. — Director | Purchase (P): 2,835 @ $3.64 | EDGAR |
| 2024-05-17 | 4 | Thomas Steffen — Director | Purchase (P): 5,000 @ $4.52 | EDGAR |
| 2024-04-01 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Option exercise (M): 73,380 @ $1.32 · Sale (S): 73,380 @ $5.11 · Option exercise (M): 73,380 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Donhauser Peter D.O. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Velden Claus Vander — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Thomas Steffen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Ma Jiong — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Skarpelos Athanasios — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-06-30 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Option exercise (M): 268,000 @ $1.60 · Sale (S): 268,000 @ $7.98 · Option exercise (M): 232,000 @ $1.60 · Option exercise (M): 268,000 (derivative) @ $0 · Option exercise (M): 232,000 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Ma Jiong — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Thomas Steffen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Velden Claus Vander — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Donhauser Peter D.O. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Skarpelos Athanasios — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — ANAVEX LIFE SCIENCES CORP.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-28 | 8-K | 5.01 — Changes in Control of Registrant 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-09-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-26 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AVXL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →